Ivermectin-Induced Clinical Improvement and Alleviation of Significant Symptoms of COVID-19 Outpatients: A Cross-Sectional Study

Although several drugs have been proposed and used to treat the COVID-19 virus, but recent clinical trials have concentrated on ivermectin. It appears that ivermectin can potentially act against COVID-19 and stop the development in its infancy. The purpose of this study was to determine the effect o...

Descripción completa

Detalles Bibliográficos
Autores principales: Niaee, Morteza Shakhsi, Zolghadr, Leila, Hosseinkhani, Zahra, Namdar, Peyman, Allami, Abbas, Amini, Fatemeh, Varnaseri, Mehran, Pourdast, Allieh, Gheibi, Nematollah
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510226/
https://www.ncbi.nlm.nih.gov/pubmed/36187299
http://dx.doi.org/10.1007/s40995-022-01349-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9510226/
https://www.ncbi.nlm.nih.gov/pubmed/36187299
http://dx.doi.org/10.1007/s40995-022-01349-8

Ejemplares similares